Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 26.96B | 27.90B | 29.14B | 27.83B | 26.53B | 23.46B |
Gross Profit | 13.09B | 16.41B | 16.41B | 14.04B | 14.37B | 13.12B |
EBITDA | 4.16B | 4.09B | 4.38B | 3.57B | 4.41B | 5.20B |
Net Income | 1.75B | 1.70B | 2.00B | 1.54B | 2.33B | 2.92B |
Balance Sheet | ||||||
Total Assets | 0.00 | 27.62B | 27.14B | 24.95B | 23.83B | 21.76B |
Cash, Cash Equivalents and Short-Term Investments | 3.11B | 3.11B | 1.69B | 2.66B | 1.77B | 3.44B |
Total Debt | 0.00 | 2.13B | 2.05B | 1.64B | 1.74B | 1.44B |
Total Liabilities | -20.98B | 6.64B | 7.13B | 6.40B | 6.22B | 6.03B |
Stockholders Equity | 20.98B | 20.98B | 20.01B | 18.55B | 17.60B | 15.72B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 2.91B | -132.40M | 2.15B | -835.20M | 3.90B |
Operating Cash Flow | 0.00 | 4.06B | 2.35B | 4.00B | 559.90M | 5.13B |
Investing Cash Flow | 0.00 | -2.62B | -986.30M | -2.58B | 145.50M | -4.53B |
Financing Cash Flow | 0.00 | -1.62B | -1.06B | -1.38B | -697.80M | -561.50M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
66 Neutral | ₹147.89B | 70.90 | ― | 0.78% | 0.60% | -36.73% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
60 Neutral | ₹109.12B | 62.41 | ― | 0.68% | -7.78% | -7.25% | |
58 Neutral | ₹3.02B | 40.18 | ― | ― | 40.33% | ― | |
55 Neutral | ₹4.54B | 86.25 | ― | ― | -16.46% | -2.33% | |
55 Neutral | ₹52.47B | 71.29 | ― | ― | 93.58% | 93.53% |
Relaxo Footwears Limited announced its unaudited financial results for the quarter ending June 30, 2025, revealing a revenue from operations of INR 654.49 crore and a profit before tax of INR 65.91 crore. The results, reviewed by M/s Gupta & Dua, Chartered Accountants, indicate a stable financial performance, with the company continuing to maintain its market position. This announcement is expected to reassure stakeholders about the company’s ongoing operational stability and financial health.